Market Overview:
The global lung surfactants market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of respiratory diseases, rising awareness about early diagnosis and treatment of respiratory diseases, and technological advancements in the field of lung surfactants. The global lung surfactants market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into intratracheal and injectable. Intratracheal was a dominant segment in 2017 owing to its high usage rates for treating respiratory distress syndrome (RDS) in newborns across hospitals globally. However, injectable is expected to grow at a higher CAGR during the forecast period as it offers several advantages over other types such as ease-of-use and lower chances of side effects.
Product Definition:
Lung surfactants are a family of specialized proteins secreted by type II pneumocytes that line the air spaces of the lungs. The primary function of lung surfactants is to reduce surface tension within the alveoli, which allows them to remain open and maximizes gas exchange. Lung surfactants also play an important role in innate immunity by inhibiting growth of bacteria and viruses.
Intratracheal:
Intratracheal is a term used for substances that are administered through the trachea (windpipe) into the lungs. The most common route of administration is by inhalation, although it can also be administered intracompany or intradermally. Intratracheal products include dry powder formulations such as freon, nebulized liquids such as saline solution and surfactant solutions, and liquid aerosols.
Injectable:
Injectable or Intravenous Surfactant (IVS) is a surfactant that can be delivered by injection into the vein. The most common type of injectable used in lung surfactants market is Sodium Lauryl Sulfate (SLS).
The advantages of using IVS are it has a very fast onset of action, it’s cost-effective.
Application Insights:
Based on the application, the global lung surfactants market has been segmented into hospital, special clinic, and recovery center. The hospital segment dominated the overall market in terms of revenue in 2017. This is due to a large number of patients suffering from respiratory disorders requiring medical treatment at hospitals or clinics. Lung surfactants are used as an expectorant and anti-diuretic agent for the treatment of pulmonary edema and respiratory distress syndrome respectively. Thus increasing demand for these drugs at a domestic level owing to its effectiveness in treating such diseases is expected to drive growth over forecast period.
The recovery center segment is anticipated to witness significant growth during the forecast period owing to rising incidences of chronic bronchitis & emphysema among adults & children across various regions including North America, Europe, Asia Pacific.
Regional Analysis:
Asia Pacific dominated the global market in 2017 and is expected to maintain its position over the forecast period. The presence of a large number of manufacturers coupled with increasing healthcare expenditure in developing economies such as China, India, and Japan are some factors contributing to regional growth. In addition, rising awareness regarding lung surfactants treatment among patients from developed countries is also expected to drive demand for these products over the forecast period.
North America accounted for a significant share owing to high product demand from various end-use industries including hospitals & clinics, recovery centers and home care units. High prevalence of chronic respiratory diseases such as asthma along with growing initiatives by regulatory bodies aimed at improving patient access to cost-effective therapies are anticipated favorably impact industry growth in this region.
Europe held a substantial revenue share in 2017 due primarily on increased sales volume of intralesional products within this region especially within Germany which has one of the largest markets for medical devices across Europe (28th position).
Growth Factors:
- Increasing incidence of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) is expected to drive the demand for lung surfactants over the forecast period.
- Rising awareness about the benefits of using lung surfactants in treatment of respiratory diseases is anticipated to propel market growth.
- Technological advancements in production process are likely to provide opportunities for market expansion over the forecast period.
- Growing demand for prophylactic surfactants owing to increasing number of preterm births is projected to fuel Lung Surfactant market growth during the forecast period .
Scope Of The Report
Report Attributes
Report Details
Report Title
Lung Surfactants Market Research Report
By Type
Intratracheal, Injectable
By Application
Hospital, Special Clinic, Recovery Center
By Companies
Chiesi Farmaceutici, AbbVie, ONY Biotech, Lyomark Pharma, Windtree Therapeutics, Aviva Systems Biology Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
210
Number of Tables & Figures
147
Customization Available
Yes, the report can be customized as per your need.
Global Lung Surfactants Market Report Segments:
The global Lung Surfactants market is segmented on the basis of:
Types
Intratracheal, Injectable
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Special Clinic, Recovery Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Chiesi Farmaceutici
- AbbVie
- ONY Biotech
- Lyomark Pharma
- Windtree Therapeutics
- Aviva Systems Biology Corporation
Highlights of The Lung Surfactants Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Intratracheal
- Injectable
- By Application:
- Hospital
- Special Clinic
- Recovery Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Lung Surfactants Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Lung surfactants are a type of medication that help to reduce the amount of air that is inhaled during breathing. Lung surfactants work by creating a surface film on the inside of the lungs, which helps to reduce the amount of air that is breathed in.
Some of the key players operating in the lung surfactants market are Chiesi Farmaceutici, AbbVie, ONY Biotech, Lyomark Pharma, Windtree Therapeutics, Aviva Systems Biology Corporation.
The lung surfactants market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Lung Surfactants Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Lung Surfactants Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Lung Surfactants Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Lung Surfactants Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Lung Surfactants Market Size & Forecast, 2020-2028
4.5.1 Lung Surfactants Market Size and Y-o-Y Growth
4.5.2 Lung Surfactants Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Intratracheal
5.2.2 Injectable
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Special Clinic
6.2.3 Recovery Center
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Lung Surfactants Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Lung Surfactants Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Intratracheal
9.6.2 Injectable
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Special Clinic
9.10.3 Recovery Center
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Intratracheal
10.6.2 Injectable
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Special Clinic
10.10.3 Recovery Center
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Intratracheal
11.6.2 Injectable
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Special Clinic
11.10.3 Recovery Center
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Intratracheal
12.6.2 Injectable
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Special Clinic
12.10.3 Recovery Center
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Intratracheal
13.6.2 Injectable
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Special Clinic
13.10.3 Recovery Center
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Lung Surfactants Market: Competitive Dashboard
14.2 Global Lung Surfactants Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Chiesi Farmaceutici
14.3.2 AbbVie
14.3.3 ONY Biotech
14.3.4 Lyomark Pharma
14.3.5 Windtree Therapeutics
14.3.6 Aviva Systems Biology Corporation
